| 1 |
Oculis Holding AG |
66,861.65 Bn |
66,861.36 Bn |
- |
-24.89% |
| 2 |
Nanobiotix |
1,911.83 Bn |
1,911.77 Bn |
- |
- |
| 3 |
Akari Therapeutics |
973.81 Bn |
973.81 Bn |
- |
- |
| 4 |
BeOne Medicines |
471.51 Bn |
466.72 Bn |
1.35 Bn |
2,150.96% |
| 5 |
Vertex Pharmaceuticals |
121.94 Bn |
114.70 Bn |
2.59 Bn |
80.62% |
| 6 |
Regeneron Pharmaceuticals |
70.05 Bn |
61.30 Bn |
3.31 Bn |
8.65% |
| 7 |
Belite Bio |
62.68 Bn |
62.68 Bn |
- |
- |
| 8 |
Argenx Se |
55.88 Bn |
50.69 Bn |
1.41 Bn |
145.20% |
| 9 |
Alnylam Pharmaceuticals |
37.49 Bn |
34.48 Bn |
959.66 Mn |
1,386.07% |
| 10 |
Aspire Biopharma Holdings |
1.09 Mn |
-736,215.39 |
5,750.00 |
89.42% |
